FDA Approves Tazarotene Lotion, 0.045%, for Acne Vulgaris
Tazarotene is the first acne treatment to be available in a lotion form, showing strong efficacy with favorable tolerability.
Related Articles
ASCO 2025: Ribociclib With NSAI in HR+/HER– Breast Cancer Improves iDFS, Yields Substantial Work Productivity Gains
Ribociclib in combination with a nonsteroidal aromatase inhibitor (NSAI) improved invasive disease-free survival (iDFS) while allowing for better quality of life in hormone receptor-positive (HR+)/human…
Beyond Dispensing: How Pharmacists and Technicians Can Expand Services to Meet Patient Needs
Pharmacists and pharmacy technicians are key to offering more accessible and efficient care.
Study Shows High-Dose Vitamin D Boosts Treatment Response in Breast Cancer
Vitamin D could offer an alternative option over hard-to-access and burdensome cancer drugs to heighten the response of chemotherapy.
Meta-Analysis Evaluates RSV Viral Load and Symptom Kinetics
New research analyzes human challenge infection studies to reveal insights on respiratory syncytial virus viral load and symptom dynamics, aiding treatment development.
Single Infusion of Cilta-Cel Yields 5-Year Progression-Free Survival in Multiple Myeloma
Cilta-cel shows promise as a CAR T-cell therapy, offering long-term remission for relapsed/refractory multiple myeloma patients without maintenance treatment.
SCIg More Effective Immunoglobulin Option for Immunocompromised Patients With Inborn Errors of Immunity
Subcutaneous immunoglobulin was found to elicit fewer viral infections compared with other routes of immunoglobulin replacement therapy, including intravenous immunoglobulin.
GLP-1 Receptor Agonists Demonstrate Increased Risk of Neovascular Age-Related Macular Degeneration in Diabetes
Patients with diabetes using glucagon-like peptide-1 (GLP-1) drugs face double the risk of developing neovascular age-related macular degeneration, highlighting crucial ocular health concerns.
Clesrovimab Receives FDA Approval for RSV Lower Respiratory Tract Prevention in Infants
The FDA approves clesrovimab-cfor, a new RSV vaccine, offering infants effective protection against severe respiratory illness during their first RSV season.
Reimagining Pain Management: Pharmacists Urged to “Deconstruct the Cupcake”
Innovative pain management strategies emerge as experts advocate for personalized, multifaceted approaches to chronic pain, likening treatment to a tailored cupcake.
ASCO 2025: Promising Safety and Efficacy of Encorafenib and Binimetinib in Resected Stage II Melanoma
A new study reveals the combination therapy enhances safety and efficacy for high-risk BRAF-mutated stage II melanoma.